A Peek Into The Markets: US Stock Futures Up Ahead Of Economic Data

Pre-open movers

U.S. stock futures traded higher in early pre-market trade. The Empire State manufacturing index for December is schedule for release at 8:30 a.m. ET, while the flash Composite Purchasing Managers' Index for December will be released at 9:45 a.m. ET. The National Association of Home Builders housing market index for December is schedule for release at 10:00 a.m. ET.

Futures for the Dow Jones Industrial Average gained 45 points to 28,210 while the Standard & Poor’s 500 index futures traded rose 10.3 points to 3,185.50. Futures for the Nasdaq 100 index gained 31.75 points to 8,552.75.

Oil prices traded higher as Brent crude futures rose 0.2% to trade at $65.34 per barrel, while US WTI crude futures rose 0.1% to trade at $60.09 a barrel.


A Peek Into Global Markets


European markets were higher today, with the Spanish Ibex Index rising 0.8%, STOXX Europe 600 Index gaining 1% and German DAX 30 index gaining 0.6%. The UK's FTSE index was trading higher by 1.9%, while French CAC 40 Index rose 0.8%.

In Asian markets, Japan’s Nikkei Stock Average fell 0.29%, Hong Kong’s Hang Seng Index dropped 0.65%, China’s Shanghai Composite Index rose 0.56% and India’s BSE Sensex fell 0.17%.


Broker Recommendation

Analysts at Jefferies initiated coverage on Amphenol Corporation APH with a Buy rating and a $125 price target.

Amphenol shares fell 0.8% to close at $107.14 on Friday.


Breaking News

  • Cineplex Inc CPXGF agreed to be acquired by Cineworld Group, plc CNWGY for $2.8 billion.
  • Amarin Corporation plc AMRN reported the FDA approval of VASCEPA to reduce cardiovascular risk. The company said it expects 2019 VASCEPA net revenue of $410 million to $425 million and 2020 VASCEPA net revenue of $650 million to $700 million.
  • Shoe Carnival, Inc. SCVL reported a $50 million buyback program and declared a quarterly cash dividend of $0.085 per share.
  • Horizon Therapeutics PLC HZNP disclosed that the FDA Advisory Committee has voted unanimously to support use of teprotumumab for Thyroid Eye Disease.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsEurozoneFuturesGlobalPre-Market OutlookMarketsA Peek Into The MarketsUS Stock Futures
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!